Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blazej Rubis

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|April 15, 2010
Accumulation of environmental estrogens in adipose tissue of breast cancer patientsMarta Ociepa-Zawal, Blazej Rubis, Dominik Wawrzynczak, et al.
Cellular and Molecular Life Sciences : CMLS|June 18, 2017
Telomerase and drug resistance in cancerNatalia Lipinska, Aleksandra Romaniuk, Anna Paszel-Jaworska, et al.
European Journal of Pharmacology|March 3, 2012
The tetramethoxyflavone zapotin selectively activates protein kinase C epsilon, leading to its down-modulation accompanied by Bcl-2, c-Jun and c-Fos decreaseEwa Toton, Natalia Lisiak, Blazej Rubis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2024
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cellsMalgorzata Kucinska, Julia Pospieszna, Jing Tang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2025
Corrigendum to "The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells" [Biomed. Pharmacother. 176 (2024) 116892]Malgorzata Kucinska, Julia Pospieszna, Jing Tang, et al.
International Journal of Biological Macromolecules|August 28, 2007
Spectroscopic study and G-quadruplex DNA binding affinity of two bioactive papaverine-derived ligandsElzbieta Galezowska, Anna Masternak, Blazej Rubis, et al.
Folia Histochemica Et Cytobiologica|October 24, 2007
Analysis of expression of MHC class I molecules and TAP genes in malignant human cell linesMariusz Kaczmarek, Magdalena Frydrychowicz, Blazej Rubis, et al.
International Journal of Molecular Sciences|March 29, 2023
Biological Activity of Oleanolic Acid Derivatives HIMOXOL and Br-HIMOLID in Breast Cancer Cells Is Mediated by ER and EGFRNatalia Lisiak, Patrycja Dzikowska, Urszula Wisniewska, et al.
Scientific Reports|April 15, 2018
hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modificationWojciech Barczak, Agnieszka Sobecka, Pawel Golusinski, et al.
Investigational New Drugs|September 6, 2008
The biological activity of G-quadruplex DNA binding papaverine-derived ligand in breast cancer cellsBlazej Rubis, Mariusz Kaczmarek, Natalia Szymanowska, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|April 15, 2010
Accumulation of environmental estrogens in adipose tissue of breast cancer patientsMarta Ociepa-Zawal, Blazej Rubis, Dominik Wawrzynczak, et al.
Cellular and Molecular Life Sciences : CMLS|June 18, 2017
Telomerase and drug resistance in cancerNatalia Lipinska, Aleksandra Romaniuk, Anna Paszel-Jaworska, et al.
European Journal of Pharmacology|March 3, 2012
The tetramethoxyflavone zapotin selectively activates protein kinase C epsilon, leading to its down-modulation accompanied by Bcl-2, c-Jun and c-Fos decreaseEwa Toton, Natalia Lisiak, Blazej Rubis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2024
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cellsMalgorzata Kucinska, Julia Pospieszna, Jing Tang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2025
Corrigendum to "The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells" [Biomed. Pharmacother. 176 (2024) 116892]Malgorzata Kucinska, Julia Pospieszna, Jing Tang, et al.
International Journal of Biological Macromolecules|August 28, 2007
Spectroscopic study and G-quadruplex DNA binding affinity of two bioactive papaverine-derived ligandsElzbieta Galezowska, Anna Masternak, Blazej Rubis, et al.
Folia Histochemica Et Cytobiologica|October 24, 2007
Analysis of expression of MHC class I molecules and TAP genes in malignant human cell linesMariusz Kaczmarek, Magdalena Frydrychowicz, Blazej Rubis, et al.
International Journal of Molecular Sciences|March 29, 2023
Biological Activity of Oleanolic Acid Derivatives HIMOXOL and Br-HIMOLID in Breast Cancer Cells Is Mediated by ER and EGFRNatalia Lisiak, Patrycja Dzikowska, Urszula Wisniewska, et al.
Scientific Reports|April 15, 2018
hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modificationWojciech Barczak, Agnieszka Sobecka, Pawel Golusinski, et al.
Investigational New Drugs|September 6, 2008
The biological activity of G-quadruplex DNA binding papaverine-derived ligand in breast cancer cellsBlazej Rubis, Mariusz Kaczmarek, Natalia Szymanowska, et al.
Pageof 3